ライフサイエンスコーパス: entity

1 cross 23 different Asia-Pacific geopolitical entities).

2 on of gemtuzumab ozogamicin (GO) in this AML entity.

3 ng safety and tolerability of a new chemical entity.

4 e 2 such patients to raise awareness of this entity.

5 to better understand and manage this disease entity.

6 of fluctuations-the reactivity RA of a given entity.

7 nose to avoid the delay in treatment of this entity.

8 .8%]); only 1 (2.1%) was for a new molecular entity.

9 to recognize BIA-ALCL as a separate disease entity.

10 lly been viewed as a conformationally static entity.

11 /m(2)) because it represents a heterogeneous entity.

12 macular degeneration is considered a single entity.

13 are sufficient for a self-propagating prion entity.

14 nment is a complex and continuously evolving entity.

15 4 h of incubation; and a tyrosine-containing entity.

16 nostic and treatment challenges of this rare entity.

17 causing the up/down-regulation of the target entity.

18 ts describe the etiology of a single disease entity.

19 t been previously demonstrated in this tumor entity.

20 ake the primary cilium a distinct functional entity.

21 a only, generating confusion between the two entities.

22 nary causal relationships between biological entities.

23 er differs from other pediatric inflammatory entities.

24 allographically and compositionally distinct entities.

25 o enhance tumor progression in several tumor entities.

26 ion of COVID-19 findings from other clinical entities.

27 rocess of grouping scene elements into whole entities.

28 tic amplification, and nanoimpacts of single entities.

29 icroscopy reveals them as spatially separate entities.

30 in DSM and ICD are actually discrete disease entities.

31 s equally important biological properties of entities.

32 findings and differential diagnosis of these entities.

33 s the cohort rather than discrete diagnostic entities.

34 of the most commonly encountered pathologic entities.

35 ating the multiple functionalities in single entities.

36 rarely used to predict genes for anatomical entities.

37 le platforms are unavailable for most cancer entities.

38 SCNs of the pancreas are invariably benign entities.

39 ruritus with no differences between pruritus entities.

40 e which is activated by structurally diverse entities.

41 quire animal toxicity tests for new chemical entities.

42 gered more readily by negative than positive entities.

43 lly relevant spatial relations between those entities.

44 nct clinical, biological and epidemiological entities.

45 or predicting candidate genes for anatomical entities.

46 ater, soil), they are not distinct, separate entities.

47 y which the immune system detects pathogenic entities.

48 plications of SPRM to the analysis of single entities.

49 tellurium-containing compounds as novel drug entities.

50 ons in the MPC for the recognition of unique entities.

51 ature review to evaluate the rare non-PGNMID entities.

52 tally identify these potentially problematic entities.

53 ature review to evaluate the rare non-PGNMID entities.

54 ted diseases rather than discrete diagnostic entities.

55 gress in genomics has revealed new monogenic entities.

56 is divided into a broad spectrum of clinical entities.

57 cers and expression of key TME genes in both entities.

58 ymes on blood tests raise suspicion of these entities.

59 in the neocortex do not always form discrete entities.

60 ed to predict candidate genes for anatomical entities.

61 which one or more lipoprotein lipid-related entities account for this relationship remains unclear.

62 most frequently detected in the mesenchymal entity, accounting for ~19% of these tumors.

63 (CT) findings of a spectrum of pathological entities affecting the duodenum.

64 , the fictional status of folk-psychological entities and (2) the degree to which they should be unde

65 Small-molecular entities and biologics acting on various stemness signal

66 d memory deficits, their distinction between entities and relational encoding is incompatible with da

67 t managers can specify annotation schema for entities and relations and select annotator(s) and distr

68 lines provide tools to automatically extract entities and relationships from the scientific literatur

69 These existing systems are built on given entities and they depend on external syntactic tools.

70 he imaging findings of the different disease entities and to evaluate them together with the patient'

71 transformers model, our model detects nested entities and triggers, roles, nested events and their mo

72 It is a rare entity and difficult to diagnose reason why it is import

73 disability (ID) is a heterogeneous clinical entity and includes an excess of males who harbor varian

74 astoma is the most common human brain cancer entity and is maintained by a glioblastoma stem cell (GS

75 lustrating the main imaging findings of this entity and reviewing its most relevant aspects, we prese

76 ides evidence that it is a discrete clinical entity and suggests targets for treatment.

77 Thus, "entity" and "relational" brain regions may need to solve

78 ect of solvent polarity, number of linked CT entities, and excitation wavelength dependence in govern

79 (DEP) can affect the response of biological entities, and ignoring the effect can result in misleadi

80 iew of abstraction, our ontology of abstract entities, and our account of predictive cognition as rel

81 ould be aware of this possibly underreported entity, and as a consequence we envision more comprehens

82 s undergone substantial change from when the entity ankylosing spondylitis was defined by the modifie

83 We used existing Uberon anatomical entity annotations for zebrafish and mouse genes to cons

84 epresent over one-third of all new molecular entities approved by FDA.

85 These virus-derived entities are passed on through wasp generations and enha

86 lecular mechanisms underlying these clinical entities are predominately different.

87 e chemical synthesis of additional molecular entities are required.

88 nical trials involving new experimental drug entities are reviewed to evaluate how far away we are fr

89 Even when gold entities are unavailable, our model can detect events fr

90 ifically target chronic itch as a pathologic entity are currently still not available.

91 ent findings that are characteristic of each entity are essential to reach the correct diagnosis.

92 that even individual objects - prototypical "entities" - are made up of distinct features which requi

93 cer in females should be considered a unique entity as compared with the presentation and treatment o

94 Important clinical entities associated with natriuretic peptide research in

95 omise for the development of new therapeutic entities because of its bifunctional role as a biomarker

96 bsurface are commonly considered as separate entities because of the difference in the bonding enviro

97 he characteristic radiological signs of this entity, because early diagnosis is essential to prevent

98 ly move an individual and specific molecular entity between two separate probes, opening avenues for

99 elopment of endogenously organized cell-like entities (biocompatible micro-bots) geared specifically

100 s a functional unit rather than as different entities, boosting their mutual functions in different p

101 rtance of considering memories not as static entities, but instead as flexible network states that re

102 estigating the functional role of single RNA entities, but studies suggest complex interaction betwee

103 orating small gold particles within a larger entity, but elimination may still be protracted due to i

104 the prediction modeling for disease-related entity, but not on the clinical implication of the featu

105 body knob domains can function as autonomous entities by binding antigen outside the confines of the

106 date gene prediction accuracy for anatomical entities by combining existing experimental knowledge ab

107 ing IR spectromicroscopy, we described a new entity called vancomycin cast nephropathy.

108 t remains an important question whether such entities can achieve the specificity of natural enzymes

109 linear and heterocyclic biologically active entities can be obtained.

110 These entities can mimic more urgent pathologies such as appen

111 clusions based on fluctuations from a single entity can be misleading when used without proper refere

112 gen storage diseases (GSDs) comprise over 15 entities caused by generalized or tissue-specific defect

113 istinct World Health Organization recognized entity, characterized by its aggressive course and poor

114 een proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc.

115 Although often considered a single-entity, chronic kidney disease (CKD) comprises many path

116 Tumor entities comprised esophageal cancer, colon cancer, rect

117 rotein-coupled receptors, and its functional entity comprises an obligate heterodimer that is compose

118 owledge bases to create a knowledge graph of entities connected to both drugs and their potential tar

119 term atrial failure as a clinically relevant entity, defined as any atrial dysfunction causing impair

120 losses was typical for the respective cancer entity, despite a few distinct differences.

121 Despite the rise in these disease entities, detailed long-term outcomes of large NAFLD-ass

122 y recognized as a separate neuropathological entity different from Alzheimer's disease.

123 The spectrum of entities discussed includes osseous and osteochondral in

124 The fact that the 2 tumor entities do not differ in their soft properties suggests

125 of such a framework would be to create novel entities (e.g. centre of excellence in academic ethics a

126 odellers can now directly search for a model entity (e.g. a protein or drug) to retrieve the rate equ

127 s partial measurements of diverse biological entities, e.g. messengerRNAs, proteins, metabolites and

128 lar cartilage constitute a single anatomical entity early in development but later separate into two

129 ctronics and give an insight on their single-entity electrochemical behaviour.

130 uses fast Fourier transforms (FFT) of single entity electrochemical transients and digital filters.

131 Herein, we apply the single-entity electrochemistry (SEE) to directly and quantitati

132 We report a new application of the single-entity electrochemistry (SEE) to in situ measure a parti

133 plays highly valuable applications of single-entity electrochemistry.

134 However, where and how these entities emerge in the primate brain and the neuronal me

135 uggests that AML, similar to other malignant entities, employs a variety of mechanisms to evade immun

136 psychiatric syndrome, not a unitary disease entity, encompassing a broad spectrum of psychopathology

137 with the ultrasonographic appearance of this entity facilitates the diagnostic orientation and manage

138 antly differentially expressed between these entities (FDR < 0.05).

139 tages over (18)F-FDG PET/CT in several tumor entities for initial staging and detection of tumor recu

140 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level Black popul

141 New chemical entities for the treatment of prostate cancer are thus r

142 , as distinguishing these low-electron dense entities from their similar liquid-phase surroundings pr

143 orically been approached as a single disease entity given the uniform association with poor clinical

144 pathic' Parkinson's disease (PD) as a single entity has been challenged with the identification of se

145 This fascinating new entity has completely changed the paradigms of allergy a

146 eir receptors, a number of new pharmacologic entities have been designed to target both T2 cytokines

147 Since then, these organometallic entities have proven to be uniquely effective in catalyz

148 Electron exchange between two TPA-TCBD entities in 3 seem to prolong lifetime of the CS state.

149 redict missing (or future) links between two entities in a complex system that are not already connec

150 10-20 years) as particularly useful chemical entities in a variety of applications.

151 and characteristic for the respective tumor entities in general.

152 perience and the statistical distribution of entities in language, especially for intangible represen

153 The genetic entities in such simulations should not be generic but s

154 re often considered to be relatively uniform entities in which nutrients can freely move through the

155 es, which are considered the main pathogenic entity in AD, as compared to rodent Abeta, the rat Amylo

156 Type 2 MNV remains a rare entity in AMD.

157 ained greater recognition as a major disease entity in children younger than 5 years.

158 he biliary tract (B-IPN) is a scarcely known entity in our daily practice due to its low prevalence.

159 NPM1-mutated AML is recognized as a distinct entity in the 2017 World Health Organization (WHO) class

160 oid proliferation, included as a provisional entity in the current World Health Organization classifi

161 es (phages) are the most abundant biological entity in the human body, but until recently the role th

162 tegration of a microporous monolithic mixing entity in the microchannels significantly narrows the re

163 l myeloid malignancies as a separate disease entity in the revised WHO classification has renewed eff

164 Enterococcal endocarditis (EE) is a growing entity in Western countries.

165 DOR, as a single entity (in combination with other antiretroviral agents)

166 on the patient population analysed, the UTI entities included and the primary outcome of the study.

167 tem, OmicsDI integrates different biological entities including genes, transcripts, proteins, metabol

168 and presenting symptoms that mimic different entities including infectious etiologies, makes this lym

169 of patients survive their injuries, several entities including the National Academies of Science, En

170 fication of genes responsible for anatomical entities is a major requirement in many fields including

171 gly similar, but potentially distinct, known entities is an inherently risky endeavor.

172 omposed of enantiomorphic domains of racemic entities is demonstrated by scanning tunneling microscop

173 ng of the semantic relatedness of biological entities is vital to many biological applications, such

174 Regarding its imaging features, this entity is characterized by a small focal bulging of the

175 n development of this histologically defined entity is injury and ultimately depletion of podocytes,

176 However, awareness of this entity is low, and a specific imaging pattern has not ye

177 rver computes the probability that the whole entity is present.

178 ently emerged as a method of studying single entities, it is limited by requirement of a catalyticall

179 ess, because glycoproteins are heterogeneous entities, it remains unclear how glycosylation modulates

180 VICE 1: The definition of SIBO as a clinical entity lacks precision and consistency; it is a term gen

181 e indicate their deployment against invasive entities, like viruses, to limit their spread in multice

182 The high mortality associated with this rare entity means it requires early accurate diagnosis.

183 (n-grams) and 2) standardized clinical named entity mentions mapped from the National Library of Medi

184 escence bring about the conclusion that both entities merge along the natural history of the disease.

185 me when compared with the standardized named entity model, although not statistically significant (C-

186 There is no known association of these two entities, more so in siblings.

187 rapping process for two different biological entities, namely, Escherichia coli bacteria and yeast ce

188 a self-delivering one-component new-chemical-entity nanomedicine (ONN) strategy to improve cancer the

189 t the hypothesis that lower molecular weight entities of disease protein are relevant pathogenic spec

190 rs to make valid inferences about biological entities of interest, even if they are pseudoreplicates,

191 ucus consists of two distinct O-glycosylated entities of Muc2: a major form produced by the proximal

192 ch Pax6 would be needed to maintain specific entities of subpopulations of neurons.

193 folds, Optimaix (laminar structure mimicking entities of the diaphysis) and DegraPol (highly porous r

194 A GSP is a graph where the nodes represent entities of the protein-ligand complex (amino acids and

195 inv(3)/t(3;3) can be classified as a single entity of 3q26-rearranged AMLs.

196 aiges et al [1] which shed light on the rare entity of Abernethy malformation and gives a working alg

197 Ependymoma is a heterogeneous entity of central nervous system tumors with well-establ

198 However, the molecular entity of the tension sensing mechanism remains elusive.

199 This novel disease entity often prompts comparisons with, and extrapolation

200 Viruses are the most abundant biological entities on Earth and play key roles in host ecology, ev

201 llular life and the most abundant biological entities on Earth.

202 Bacteriophages, the most abundant biological entity on Earth, evolve rapidly, and therefore, detectio

203 dynamic processes rather than as structural entities or memory stores.

204 without proper reference to other comparable entities or when examined only on one timescale.

205 ocytomas and paragangliomas are a rare tumor entity originating from adrenomedullary chromaffin cells

206 uals who are at risk; however, for many rare entities, our knowledge of heritable predisposition is i

207 iveness of the mammalian host-gut microbiome entity over evolutionary times.

208 At the colonization site of a foreign entity, plant cells alter their trajectory of growth and

209 The available chemical entities present with drug-like features contribute to t

210 sult in a highly adaptable and heterogeneous entity primed for therapy evasion and survival.

211 Biomedical named entity recognition (BioNER) is an important task for und

212 To develop concept embeddings, named-entity recognition (NER) tools are first used to identif

213 works advanced the state-of-the-art in named entity recognition (NER), including biomedical NER.

214 ntification (HIDE) software, and Neuro named-entity recognition (NeuroNER).

215 d FastSK to 7 English-language medical named entity recognition datasets and 10 protein remote homolo

216 are willing and capable of performing named entity recognition of disease mentions in biomedical abs

217 We confirm the importance of accurate named entity recognition on user performance of RE and identif

218 An error analysis reveals named entity recognition/normalization as the largest source o

219 curately and regard the instances containing entity relations as being independent, which neglects th

220 experimental knowledge about gene-anatomical entity relationships with PPI networks using anatomy ont

221 experimental knowledge about gene-anatomical entity relationships with PPI networks via anatomy ontol

222 mber of citations, reanalysis and biological entities reported by each dataset.

223 model, familiarity may be attributed to both entity representations and relational representations.

224 IgA nephropathy (IgAN) are separate disease entities requiring different treatment approaches.

225 structures and positions of these nanoscopic entities respond to new stimuli?

226 Although the biochemical entities responsible for the synaptotoxic activities hav

227 fragment filamentous aggregates into smaller entities, restricting aggregate size [1].

228 Assessing a new chemical entity's potential for liver toxicity is an important co

229 lts, obtained in diverse hematologic disease entities, show that common targets (TE) activated by the

230 gG4-RD) has only existed as a unique disease entity since 2003, yet remarkable progress has already b

231 g 9 key elements: (1) Purpose and scope; (2) Entities, state variables, and scales; (3) Initializatio

232 Therefore, AMVP is a clinical entity strongly associated with outcome and warrants car

233 However, the entities studied in these two tasks (i.e., drugs, target

234 is a particular visual sensitivity to social entities such as faces and bodies.

235 ed colour enables the creation of perceptual entities such as metamers-non-overlapping spectral compo

236 ion is not only attuned to socially relevant entities, such as bodies, but also to socially relevant

237 A massive number of biological entities, such as genes and mutations, are mentioned in

238 er people's sense of commitment to non-human entities, such as ideals, values, and moral principles.

239 The generation of many novel functional entities, such as lncRNAs, that fuels organismal complex

240 r isolating, measuring, and annotating these entities suggests that caution in interpreting results i

241 Food systems are complex entities that affect diets, human health, and a range of

242 Less common entities that can occur are pancreatic saponification, h

243 on), provided they know the key findings for entities that can simulate COVID-19 pneumonia.

244 e rheumatic diseases are genetically complex entities that can vary widely in terms of prognosis, sub

245 t SMAPs are autonomous extracellular killing entities that deliver cytotoxic cargo targeted by the sp

246 Proteins are dynamical entities that undergo a plethora of conformational chang

247 nthesis of a new class of chimeric catalytic entities that would feature both catalytic capabilities.

248 creasingly recognized as a distinct biologic entity that can adversely affect outcomes before and aft

249 IR-CAP is best described as CIAP, a distinct entity that deserves its recognition in view of responsi

250 TKOS is an exceedingly rare clinical entity that does not contribute meaningfully to either s

251 est that p44/p62 acts as a novel DNA-binding entity that enhances damage recognition in TFIIH.

252 have led to a picture of the replisome as an entity that freely exchanges DNA polymerases and display

253 eded for the diagnosis of JRCH, an important entity that is commonly misdiagnosed as disc edema or ch

254 (Building a Synthetic Cell) aim to build an entity that mimics how living cells work.

255 They are a complex entity that presents great variability depending on the

256 Small renal masses are now a clinical entity that require management different from the approa

257 Our findings introduce a unique chemical entity that targets Abeta and tau concurrently by mimick

258 idoglycan is synthesized by three functional entities, the divisome, the elongasome, and bifunctional

259 bacterial DNA into a distinct organelle-like entity, the nucleoid.

260 dic details, frequently focusing on physical entities, their ongoing activities, and their appearance

261 ols could help locate the potential chemical entity, thereby reducing the time and resources required

262 ional approach of primarily defining disease entities through similar clinical features.

263 transport of low molecular weight drug-like entities through the network.

264 tanding of this clinically important disease entity through a genome-wide association study.

265 ins which transform into a single new living entity through cell-cell interactions, migration or cell

266 e clinical and immunologic features of these entities to define common elements for future study.

267 Therefore, new chemical entities to treat CDI are needed.

268 ptors are favorable multifunctional chemical entities to treat or decelerate the evolution of differe

269 old and demonstrated the ability of the lead entity to induce a pro-Th17 cytokine profile from primar

270 ing RNA (siRNA) duplexes, SNAs act as single-entity transfection and gene silencing agents and have b

271 In the photocurrent single entity transients, we demonstrate resolving a step small

272 he data support that GJA1-20k, an endogenous entity translated independently of Cx43, is critical for

273 tools GNormPlus and tmChem by 5-13 pp on the entity types chemicals, species and genes.

274 t corpora covering five different biomedical entity types, yielding an average increase in F1-score o

275 incorporating fully trained models for five entity types.

276 homa (ENKTL) is a unique clinicopathological entity, typically associated with poor survival outcomes

277 imperative to study these systems as dynamic entities using both simulations and experiments.

278 neuron/astrocyte and neuron/oligodendrocyte entities was termed as neuron-glia integrity recently.

279 Through the description of this genetic entity, we emphasize the possibility of dual mode of tra

280 laining the formation of only three discrete entities when five could form in principle.

281 thers are increasingly recognized as disease entities, where dysregulated cytokines contribute substa

282 SMM is a genetically mature entity whereby most driver genetic alterations have alre

283 ge functionalization to access new molecular entities which can be employed in medicinal chemistry re

284 nt dispersion syndrome (PDS) is a well-known entity which can lead to pigmentary glaucoma (PG).

285 BPs thus constitute an autonomous functional entity which processes recently formed peptidoglycan syn

286 cancers (SPCs) are becoming a common cancer entity, which may interfere with survival in relatively

287 This new entity, which we term COVID-19-associated nephropathy (C

288 se of an exponentially replicating, evolving entity whose biology is not fully characterized (e.g., p

289 the authors propose that all individuals and entities with access to clinical data become data stewar

290 tors can form previously unknown heteromeric entities with distinctive functional properties.

291 ature, we have collected 218 unique chemical entities with documented modulatory activities at homome

292 Hodgkin lymphoma (NLPHL) is a rare lymphoma entity with distinct pathologic and clinical characteris

293 boundary and the ability to manipulate this entity with electric field on the nanoscale expand the e

294 rimary age-related tauopathy, a pathological entity with features that strongly overlap with those of

295 gest series of PTH-CH defines it as a unique entity with specific evolutive profile.

296 re of the 1:1 complex constitutes a discrete entity with weak intermolecular orbital overlap between

297 Each of these represents a distinct disease entity, with different clinical and pathologic findings.

298 cheating confers an advantage to individual entities within a group, competition between groups favo

299 the nitrogen atom, into a versatile chemical entity would be a powerful strategy for introducing func

300 ion of the inhibitor with a cell-penetrating entity yielded a cell-permeable proteomimetic that activ